NUS - Nu Skin Enterprises Inc Stock Price, Fair Value and News

12.45USD-0.30 (-2.35%)Market Closed

Market Summary

USD12.45-0.30

Market Closed

-2.35%

NUS Stock Price

View Fullscreen

NUS RSI Chart

NUS Valuation

Market Cap

615.3M

Price/Earnings (Trailing)

71.59

Price/Sales (Trailing)

0.31

EV/EBITDA

8.59

Price/Free Cashflow

10.23

NUS Price/Sales (Trailing)

NUS Profitability

EBT Margin

1.35%

Return on Equity

1.05%

Return on Assets

0.48%

Free Cashflow Yield

9.78%

NUS Fundamentals

NUS Revenue

Revenue (TTM)

2.0B

Rev. Growth (Yr)

-6.45%

Rev. Growth (Qtr)

-2.03%

NUS Earnings

Earnings (TTM)

8.6M

Earnings Growth (Yr)

-87.27%

Earnings Growth (Qtr)

119.71%

Breaking Down NUS Revenue

Last 7 days

3.9%

Last 30 days

3.7%

Last 90 days

-30.2%

Trailing 12 Months

-68.9%

How does NUS drawdown profile look like?

NUS Financial Health

Current Ratio

2.13

Debt/Equity

0.58

Debt/Cashflow

0.25

NUS Investor Care

Buy Backs (1Y)

0.08%

Diluted EPS (TTM)

0.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	2.1B	2.0B	2.0B	2.0B
2022	2.6B	2.5B	2.4B	2.2B
2021	2.7B	2.8B	2.8B	2.7B
2020	2.3B	2.3B	2.4B	2.6B
2019	2.7B	2.6B	2.5B	2.4B
2018	2.4B	2.6B	2.7B	2.7B
2017	2.2B	2.2B	2.1B	2.3B
2016	2.2B	2.2B	2.2B	2.2B
2015	2.4B	2.4B	2.3B	2.2B
2014	3.3B	3.3B	3.0B	2.6B
2013	2.2B	2.3B	2.7B	3.2B
2012	1.8B	2.0B	2.0B	2.1B
2011	1.6B	1.6B	1.6B	1.7B
2010	0	1.4B	1.5B	1.5B
2009	0	1.3B	1.3B	1.3B
2008	0	0	0	1.2B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Nu Skin Enterprises Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 25, 2024	lipman andrew d	sold	-24,640	12.32	-2,000	-
Mar 11, 2024	battle emma s.	acquired	222	13.1	17.00	-
Mar 06, 2024	woodbury edwina d	acquired	102	12.82	8.00	-
Feb 27, 2024	napierski ryan s	acquired	-	-	189,574	president and ceo
Feb 27, 2024	hatchett steven keith	acquired	-	-	39,495	chief product officer
Feb 27, 2024	thomas james d	acquired	-	-	43,444	chief financial officer
Feb 27, 2024	clark chayce david	acquired	-	-	69,116	evp and general counsel
Feb 26, 2024	lipman andrew d	sold	-24,920	12.46	-2,000	-
Feb 15, 2024	hatchett steven keith	sold (taxes)	-38,613	13.82	-2,794	chief product officer
Feb 15, 2024	clark chayce david	sold (taxes)	-77,198	13.82	-5,586	evp and general counsel

Which funds bought or sold NUS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Gradient Investments LLC	unchanged	-	-6.00	15.00	-%
Apr 23, 2024	FIFTH THIRD BANCORP	reduced	-23.28	-8,704	10,483	-%
Apr 23, 2024	Global Retirement Partners, LLC	reduced	-99.36	-21,929	111	-%
Apr 23, 2024	Louisiana State Employees Retirement System	reduced	-0.81	-140,839	338,835	0.01%
Apr 23, 2024	AMALGAMATED BANK	reduced	-8.91	-120,000	223,000	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	-46,435	503,774	-%
Apr 19, 2024	Maryland State Retirement & Pension System	unchanged	-	-125,011	223,714	-%
Apr 19, 2024	State of Alaska, Department of Revenue	reduced	-0.98	-174,000	416,000	-%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	sold off	-100	-252,615	-	-%
Apr 18, 2024	FARMERS & MERCHANTS INVESTMENTS INC	unchanged	-	-196	484	-%

Are Funds Buying or Selling NUS?

Are funds buying NUS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NUS

No. of Funds

Unveiling Nu Skin Enterprises Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	12.58%	6,215,151	SC 13G/A
Feb 09, 2024	invesco ltd.	5.8%	2,856,897	SC 13G
Feb 08, 2024	wellington management group llp	0.00%	0	SC 13G/A
Jan 25, 2024	state street corp	5.81%	2,871,749	SC 13G/A
Jan 22, 2024	blackrock inc.	17.2%	8,508,678	SC 13G/A
Aug 09, 2023	state street corp	6.11%	3,051,276	SC 13G/A
Feb 13, 2023	renaissance technologies llc	4.63%	2,287,596	SC 13G/A
Feb 09, 2023	vanguard group inc	13.13%	6,490,840	SC 13G/A
Feb 09, 2023	state street corp	14.94%	7,384,649	SC 13G/A
Feb 06, 2023	wellington management group llp	7.15%	3,535,969	SC 13G/A

Recent SEC filings of Nu Skin Enterprises Inc

View All Filings

Date Filed	Form Type	Document
Apr 12, 2024	ARS	ARS
Apr 12, 2024	DEF 14A	DEF 14A
Apr 12, 2024	DEFA14A	DEFA14A
Apr 01, 2024	4	Insider Trading
Mar 25, 2024	144	Notice of Insider Sale Intent
Mar 25, 2024	4	Insider Trading
Mar 19, 2024	3	Insider Trading
Mar 18, 2024	8-K	Current Report
Mar 06, 2024	4	Insider Trading
Feb 28, 2024	4	Insider Trading

Peers (Alternatives to Nu Skin Enterprises Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	383.7B	84.1B	-0.11%	3.28%	25.37	4.56	3.82%	5.63%
CL	73.2B	19.5B	-0.70%	13.74%	31.81	3.76	8.29%	28.85%
EL	52.8B	15.2B	4.01%	-41.28%	109.39	3.49	-7.33%	-68.01%
CHD	26.2B	5.9B	1.99%	16.13%	34.64	4.46	9.16%	82.56%
CLX	18.3B	7.3B	-3.18%	-11.03%	229.24	2.51	3.47%	-81.61%
COTY	10.5B	6.0B	-0.76%	-2.91%	32.35	1.74	14.07%	132.95%
ELF	9.8B	890.1M	-13.82%	86.82%	75.8	11.02	79.24%	176.22%
MID-CAP
IPAR	4.2B	1.3B	-5.54%	-16.25%	27.38	3.17	21.26%	26.23%
NWL	3.0B	8.1B	-6.79%	-40.80%	-7.61	0.36	-14.02%	-296.95%
HIMS	2.6B	872.0M	-24.43%	4.49%	-109.62	2.96	65.49%	64.15%
HELE	2.2B	2.0B	-10.88%	16.86%	13.29	1.08	-7.82%	10.32%
SMALL-CAP
EPC	1.9B	2.3B	0.24%	-14.32%	17.82	0.84	4.31%	6.67%
ACU	149.0M	191.5M	-6.98%	52.19%	8.38	0.78	-1.27%	486.29%
GROV	56.4M	259.3M	-6.36%	244.68%	-1.3	0.22	-19.36%	50.71%
UG	38.1M	10.9M	1.24%	-18.84%	14.75	3.5	-14.28%	0.46%

Nu Skin Enterprises Inc News

Latest updates

Nu Skin Enterprises Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-2.0%	489	499	500	481	522	538	561	605	673	641	704	677	748	703	612	518	583	590	624	624	683
Gross Profit	20.6%	352	292	365	348	375	364	413	443	500	482	532	506	553	520	458	392	443	450	469	477	521
Operating Expenses	5.6%	336	319	322	332	347	385	361	391	479	417	447	444	465	446	400	356	388	380	395	408	503
S&GA Expenses	-3.4%	181	188	185	188	201	216	219	243	263	260	281	276	295	281	249	206	228	232	246	250	269
EBITDA Margin	-11.9%	0.05*	0.06*	0.06*	0.06*	0.07*	0.07*	0.10*	0.11*	0.11*	0.14*	0.14*	0.13*	-	-	-	-	-	-	-	-	-
Income Taxes	-17.8%	2.00	3.00	10.00	3.00	-32.86	-3.60	9.00	12.00	28.00	18.00	22.00	17.00	18.00	18.00	18.00	11.00	13.00	21.00	25.00	23.00	32.00
Earnings Before Taxes	127.1%	9.00	-34.45	37.00	15.00	24.00	-28.96	43.00	51.00	18.00	68.00	81.00	64.00	91.00	75.00	60.00	30.00	54.00	65.00	71.00	66.00	14.00
EBT Margin	-35.0%	0.01*	0.02*	0.02*	0.03*	0.04*	0.03*	0.07*	0.08*	0.09*	0.11*	0.11*	0.11*	-	-	-	-	-	-	-	-	-
Net Income	119.7%	7.00	-36.95	27.00	11.00	57.00	-25.39	34.00	39.00	-9.23	50.00	59.00	47.00	73.00	56.00	42.00	20.00	40.00	44.00	46.00	43.00	-17.76
Net Income Margin	-85.1%	0.00*	0.03*	0.03*	0.04*	0.05*	0.02*	0.05*	0.05*	0.05*	0.08*	0.08*	0.08*	-	-	-	-	-	-	-	-	-
Free Cashflow	-13.6%	34.00	39.00	21.00	-33.56	12.00	3.00	37.00	-2.74	91.00	17.00	3.00	-38.23	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	0.7%	1,806	1,793	1,894	1,825	1,821	1,763	1,901	1,892	1,906	1,974	2,050	1,950	1,957	1,817	1,794	1,746	1,769	1,737	1,791	1,755	1,694
Current Assets	0.1%	702	701	793	774	760	778	883	849	873	891	962	901	903	772	786	730	740	739	788	748	799
Cash Equivalents	9.7%	256	233	236	230	265	294	364	302	340	282	355	339	403	367	376	353	336	320	361	310	387
Inventory	-3.8%	280	291	372	367	346	327	354	382	400	415	391	363	314	270	262	257	276	283	293	304	296
Net PPE	0.9%	433	429	430	438	445	433	443	449	454	464	474	464	468	456	445	449	454	448	443	446	465
Goodwill	0.6%	231	229	20.00	206	206	206	206	206	206	216	216	203	203	197	197	197	197	197	197	197	197
Liabilities	1.4%	984	971	998	932	924	921	960	958	994	1,038	1,132	1,079	1,063	989	1,002	946	894	891	956	944	913
Current Liabilities	-24.2%	329	434	445	373	359	366	384	494	530	541	616	562	543	466	485	420	357	368	415	402	440
Long Term Debt	31.7%	478	363	368	373	377	382	387	259	269	279	288	298	305	313	320	327	334	342	349	356	361
LT Debt, Current	-82.1%	25.00	140	140	48.00	25.00	43.00	40.00	110	108	110	153	90.00	30.00	30.00	95.00	95.00	28.00	25.00	60.00	45.00	69.00
LT Debt, Non Current	31.7%	478	363	368	373	377	382	387	259	269	279	288	298	305	313	320	327	334	342	349	356	361
Shareholder's Equity	0.0%	822	822	895	893	897	842	941	934	913	936	918	871	894	827	792	800	875	846	835	811	782
Retained Earnings	-0.6%	1,870	1,882	1,939	1,931	1,939	1,901	1,946	1,931	1,912	1,940	1,909	1,869	1,841	1,786	1,749	1,727	1,728	1,708	1,685	1,659	1,636
Additional Paid-In Capital	0.4%	622	619	616	611	613	610	606	599	602	591	587	579	580	570	563	558	558	557	556	553	553
Shares Outstanding	-0.2%	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	51.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	1,640	-	-	-	2,170	-	-	-	2,800	-	-	-	1,940	-	-	-	2,700	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	6.2%	54,167	51,027	35,522	-22,077	25,525	28,441	46,555	7,541	109,509	30,214	20,715	-18,856	94,693	118,367	97,054	69,027	49,903	53,551	82,663	-8,186	88,888
Share Based Compensation	-16.3%	3,118	3,725	4,801	4,002	3,047	3,171	2,022	4,127	6,718	3,093	6,580	6,803	8,621	7,115	4,869	3,455	260	1,015	3,593	5,041	6,298
Cashflow From Investing	-29.3%	-15,398	-11,906	-92,501	-14,696	-13,385	-25,211	-18,350	-10,133	-15,577	-17,914	-36,439	-18,796	-29,489	-21,450	-9,305	-19,184	-13,283	-23,683	-16,304	-18,142	-33,523
Cashflow From Financing	47.2%	-20,265	-38,374	67,989	1,380	-50,794	-61,109	46,158	-33,759	-35,916	-80,019	29,388	-18,155	-41,839	-110,794	-69,554	-22,979	-25,552	-62,570	-13,705	-52,967	-57,904
Dividend Payments	-1.1%	19,269	19,486	19,475	19,392	19,027	19,303	19,392	19,293	18,936	19,007	19,040	19,289	19,100	19,245	19,356	20,686	20,553	20,552	20,553	20,531	20,186
Buy Backs	-100.0%	-	13,011	-	-	10,007	40,028	10,004	10,006	10,005	10,005	10,004	50,406	16,973	19,994	46,481	60,886	-	-	-	825	21,343

NUS Income Statement

2023-12-31

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Consolidated Statements of Income [Abstract]
Revenue	$ 1,969,131	$ 2,225,659	$ 2,695,669
Cost of sales	611,850	630,915	675,223
Gross profit	1,357,281	1,594,744	2,020,446
Operating expenses:
Selling expenses	742,365	879,634	1,080,153
General and administrative expenses	546,858	555,769	654,431
Restructuring and impairment expenses	19,790	48,494	51,870
Total operating expenses	1,309,013	1,483,897	1,786,454
Operating income	48,268	110,847	233,992
Other income (expense), net (Note 17)	(21,690)	(21,877)	(1,533)
Income before provision for income taxes	26,578	88,970	232,459
Provision (benefit) for income taxes	17,983	(15,808)	85,193
Net income	$ 8,595	$ 104,778	$ 147,266
Net income per share:
Basic (in dollars per share)	$ 0.17	$ 2.1	$ 2.93
Diluted (in dollars per share)	$ 0.17	$ 2.07	$ 2.86
Weighted-average common shares outstanding:
Basic (in shares)	49,711	50,002	50,193
Diluted (in shares)	49,860	50,525	51,427

NUS Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 256,057	$ 264,725
Current investments	11,759	13,784
Accounts receivable, net	72,879	47,360
Inventories, net	279,978	346,183
Prepaid expenses and other	81,198	87,816
Total current assets	701,871	759,868
Property and equipment, net	432,965	444,806
Operating lease right-of-use assets	90,107	98,734
Goodwill	230,768	206,432
Other intangible assets, net	105,309	66,701
Other assets	245,443	244,429
Total assets	1,806,463	1,820,970
Current liabilities
Accounts payable	43,505	53,963
Accrued expenses	260,366	280,280
Current portion of long-term debt	25,000	25,000
Total current liabilities	328,871	359,243
Operating lease liabilities	70,943	76,540
Long-term debt	478,040	377,466
Other liabilities	106,641	110,425
Total liabilities	984,495	923,674
Commitments and contingencies (Notes 7 and 16)
Stockholders' equity
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	621,853	613,278
Treasury stock, at cost - 41.1 million and 41.1 million shares	(1,570,440)	(1,569,061)
Accumulated other comprehensive loss	(100,006)	(86,509)
Retained earnings	1,870,470	1,939,497
Total stockholders' equity	821,968	897,296
Total liabilities and stockholders' equity	$ 1,806,463	$ 1,820,970

About Nu Skin Enterprises Inc

Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

CEO	Mr. Ryan S. Napierski
WEBSITE	nuskin.com
INDUSTRY	Household Products
EMPLOYEES	3800

Nu Skin Enterprises Inc Frequently Asked Questions

What is the ticker symbol for Nu Skin Enterprises Inc? What does NUS stand for in stocks?

NUS is the stock ticker symbol of Nu Skin Enterprises Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nu Skin Enterprises Inc (NUS)?

As of Tue Apr 23 2024, market cap of Nu Skin Enterprises Inc is 630.12 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NUS stock?

You can check NUS's fair value in chart for subscribers.

What is the fair value of NUS stock?

You can check NUS's fair value in chart for subscribers. The fair value of Nu Skin Enterprises Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nu Skin Enterprises Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NUS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nu Skin Enterprises Inc a good stock to buy?

The fair value guage provides a quick view whether NUS is over valued or under valued. Whether Nu Skin Enterprises Inc is cheap or expensive depends on the assumptions which impact Nu Skin Enterprises Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NUS.

What is Nu Skin Enterprises Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, NUS's PE ratio (Price to Earnings) is 73.31 and Price to Sales (PS) ratio is 0.32. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Nu Skin Enterprises Inc's stock?

In the past 10 years, Nu Skin Enterprises Inc has provided -0.155 (multiply by 100 for percentage) rate of return.